Pristiq vs. Viibryd

See how Pristiq and Viibryd compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Pristiq and Viibryd are both FDA-approved for major depressive disorder in adults but work differently: Pristiq is an SNRI, while Viibryd is a serotonin partial agonist and reuptake inhibitor.

  • Pristiq starts and stays at a fixed 50 mg dose with no titration, while Viibryd requires a two-week dose increase and must be taken with food to absorb properly.

  • Pristiq's most common side effects are nausea and dry mouth, while Viibryd's are dominated by gastrointestinal issues like diarrhea and nausea.

Pristiq vs. Viibryd Drug Summary

Pristiq

Pristiq (desvenlafaxine) is a serotonin-norepinephrine reuptake inhibitor (SNRI) approved to treat major depressive disorder in adults. It's taken once daily as an extended-release tablet, and the 50 mg starting dose is also the full therapeutic dose, so no titration is typically needed.

Viibryd

Viibryd (vilazodone) is a serotonin partial agonist and reuptake inhibitor (SPARI) approved to treat major depressive disorder in adults. It's taken once daily with food, starting at a lower dose and increasing over two weeks to reach the 40 mg maintenance dose.

Pristiq vs. Viibryd Side Effects

Pristiq

Most common
nausea (up to 41%)
dizziness (up to 16%)
dry mouth (up to 25%)
constipation (up to 14%)

Viibryd

Most common
nausea (up to 23%)
dizziness (up to 5%)
diarrhea (up to 28%)
insomnia (6% to 7%)

Pristiq vs. Viibryd Dosage

Pristiq

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 50 mg once daily At the start
Maximum dose 50 mg once daily Same as starting
Dose changes None Fixed dose

Viibryd

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 10 mg once daily Days 1-7
Maximum dose 40 mg once daily Day 15 onward
Dose changes 2 increases Every 7 days

Pristiq vs. Viibryd Indications

Pristiq

Pristiq is FDA-approved only for major depressive disorder in adults. It has not been studied for pediatric use, and people with significant kidney impairment need a lower dose.

  • Major depressive disorder (MDD) in adults

  • Not approved for pediatric patients

  • Requires dose adjustment in end-stage renal disease

  • Once-daily oral extended-release tablet

Viibryd

Viibryd is FDA-approved only for major depressive disorder in adults, the same single indication as Pristiq. It is not approved for pediatric MDD, and its absorption depends heavily on taking it with food.

  • Major depressive disorder (MDD) in adults

  • Not approved for pediatric MDD

  • Must be taken with food for proper absorption

  • Once-daily oral tablet

Pristiq vs. Viibryd Pros and Cons

Pristiq

Pristiq's biggest practical advantage is simplicity: there's no titration schedule, and the 50 mg starting dose is also the full therapeutic dose. Generic desvenlafaxine is available, though nausea, dry mouth, and other side effects are relatively common.

Pros

  • No titration schedule needed before reaching the therapeutic dose

  • Can be taken with or without food

  • Generic desvenlafaxine offers cost savings over brand

Cons

  • Nausea and dry mouth are common, affecting a large share of users

  • Requires dose adjustment in significant kidney impairment

  • Higher doses showed no added benefit, limiting dose flexibility

Viibryd

Viibryd's mechanism, partial 5-HT1A receptor agonism plus reuptake inhibition, gives it a distinct profile from typical SSRIs and SNRIs like Pristiq. It requires a two-week titration and must be taken with food, and it has no widely available generic despite FDA generic approval.

Pros

  • Distinct partial-agonist mechanism may help those who haven't responded to SSRIs/SNRIs

  • Gradual two-week titration may ease early tolerability

  • Lower reported rate of dry mouth than Pristiq (up to 5% vs up to 25%)

Cons

  • Must be taken with food or absorption drops significantly

  • No widely available generic despite FDA generic approval

  • Requires a two-week titration before reaching the full dose

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.